|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | |
| A61K 31/5025 | |||
| A61P 25/22 | |||
| A61K 31/4375 | |||
| A61K 31/519 | |||
| C07D 471/12 | |||
| A61K 31/4985 | |||
| A61P 25/00 |
| (11) | Number of the document | 2540722 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12186384.9 |
| Date of filing the European patent application | 2007-10-16 | |
| (97) | Date of publication of the European application | 2013-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2016-06-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 851983 P | 2006-10-16 | US |
| (72) |
Baell, Jonathan Bayldon, AU
Sleebs, Brad, AU
Flynn, Bernard Luke, AU
Street, Ian Phillip, AU
Quazi, Nurul, AU
Bui, Chinh Thien, AU
|
| (73) |
Bionomics Limited,
31 Dalgleish Street, Thebarton, South Australia 5031,
AU
|
| (54) | Novel anxiolytic compounds |
| Novel anxiolytic compounds |